文献速递神经肌肉病

ASC-1是细胞周期调控因子,与严重和轻度肌病相关

ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy.
PubMed 文献 · Ann Neurol · 2019-12-27

研究在5个家系中鉴定出7个TRIP4新突变,所有突变均导致ASC-1蛋白缺失,临床表型从致死性新生儿肌病到轻度可行走成人肌病。细胞实验显示ASC-1缺失加速增殖、改变细胞周期蛋白表达并缩短G0/G1期,导致细胞体积减小。

要点

  • TRIP4突变导致ASC-1蛋白缺失,引起纯肌病表型,范围从致死性新生儿到轻度成人。
  • 临床可表现为早发轴性和近端无力、脊柱侧弯、 rigid spine、特殊面容、呼吸衰竭及扩张型心肌病。
  • ASC-1是新的细胞周期调控因子,其缺失通过加速增殖和缩短G0/G1期导致细胞体积减小。

核心结论

  • TRIP4相关疾病表型谱扩展至轻度成人型肌病,可伴或不伴心肌病。
  • ASC-1缺失与孤立性原发性肌肉受累相关,TRIP4是多种先天性肌病的致病基因。
  • ASC-1被鉴定为新的细胞周期调控因子,在细胞增殖中起关键作用。

研究设计与样本

  • 对5个家系进行临床、分子、组织学和磁共振成像研究,鉴定出7个TRIP4新突变。
  • 在患者来源的成纤维细胞和肌肉以及Trip4敲低的C2C12细胞中进行荧光激活细胞分选和Western blot。

主要发现

  • 所有突变均导致ASC-1蛋白缺失。
  • 临床表型为纯肌病,范围从致死性新生儿到轻度可行走成人,包括早发轴性和近端无力、脊柱侧弯、rigid spine、特殊面容、皮肤受累、呼吸衰竭,老年病例出现扩张型心肌病。
  • 肌肉活检显示多微小轴空、线状体、胞质体、帽状结构、中央核、镶边纤维和/或轻度肌内膜纤维化。
  • ASC-1缺失导致加速增殖、细胞周期蛋白表达改变和/或G0/G1期缩短,导致细胞体积减小。

关键数值与推荐

  • 7个TRIP4新突变均导致ASC-1蛋白缺失。
  • 临床表型范围从致死性新生儿到轻度可行走成人,老年病例出现扩张型心肌病。
  • 肌肉活检可见多微小轴空、线状体、胞质体、帽状结构、中央核、镶边纤维和/或轻度肌内膜纤维化。

临床怎么用

  • 对早发轴性和近端无力、脊柱侧弯、rigid spine、特殊面容、皮肤受累、呼吸衰竭及扩张型心肌病的患者,应考虑TRIP4相关肌病。
  • 肌肉活检显示多微小轴空、线状体、胞质体、帽状结构、中央核、镶边纤维等结构异常时,可进行TRIP4基因检测。
  • TRIP4相关肌病可表现为轻度成人型,不应仅根据严重程度排除诊断。

局限性

  • 研究基于5个家系,样本量有限。
  • 未明确报告突变的具体功能实验细节及基因型-表型关联的统计效力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recently, the ASC-1 complex has been identified as a mechanistic link between amyotrophic lateral sclerosis and spinal muscular atrophy (SMA), and 3 mutations of the ASC-1 gene TRIP4 have been associated with SMA or congenital myopathy. Our goal was to define ASC-1 neuromuscular function and the phenotypical spectrum associated with TRIP4 mutations. METHODS: Clinical, molecular, histological, and magnetic resonance imaging studies were made in 5 families with 7 novel TRIP4 mutations. Fluorescence activated cell sorting and Western blot were performed in patient-derived fibroblasts and muscles and in Trip4 knocked-down C2C12 cells. RESULTS: All mutations caused ASC-1 protein depletion. The clinical phenotype was purely myopathic, ranging from lethal neonatal to mild ambulatory adult patients. It included early onset axial and proximal weakness, scoliosis, rigid spine, dysmorphic facies, cutaneous involvement, respiratory failure, and in the older cases, dilated cardiomyopathy. Muscle biopsies showed multiminicores, nemaline rods, cytoplasmic bodies, caps, central nuclei, rimmed fibers, and/or mild endomysial fibrosis. ASC-1 depletion in C2C12 and in patient-derived fibroblasts and muscles caused accelerated proliferation, altered expression of cell cycle proteins, and/or shortening of the G0/G1 cell cycle phase leading to cell size reduction. INTERPRETATION: Our results expand the phenotypical and molecular spectrum of TRIP4-associated disease to include mild adult forms with or without cardiomyopathy, associate ASC-1 depletion with isolated primary muscle involvement, and establish TRIP4 as a causative gene for several congenital muscle diseases, including nemaline, core, centronuclear, and cytoplasmic-body myopathies. They also identify ASC-1 as a novel cell cycle regulator with a key role in cell proliferation, and underline transcriptional coregulation defects as a novel pathophysiological mechanism. ANN NEUROL 2020;87:217-232.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Villar-Quiles RN, Catervi F, Cabet E, et al. ASC-1 Is a Cell Cycle Regulator Associated with Severe and Mild Forms of Myopathy. Ann Neurol. 2019. PMID: 31794073. doi:10.1002/ana.25660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。